Tislelizumab
BeiGene
[]
few more datasets to highlight to round out day 1 of #gi23. rationale-305 is another positive chemo-io trial in gej/gc 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.